Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry D Anderson

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Future Oncology (London, England)|December 2, 2021
Idecabtagene vicleucel (ide-cel) CAR T-cell therapy for relapsed and refractory multiple myelomaLarry D Anderson
British Journal of Haematology|January 7, 2022
More key players in the game for myeloma prognosis and therapyLarry D Anderson
Cancers|September 23, 2022
Preface of the Special Issue "COVID-19 Infection and Hematological Malignancies"Mingyi Chen, Larry D Anderson
Clinical Anatomy (New York, N.Y.)|September 1, 2006
Leptomeningeal plaques, a "common" findingRichard M Lovering, Larry D Anderson
Anatomical Science International|January 23, 2009
Architecture and fiber type of the pyramidalis muscleRichard M Lovering, Larry D Anderson
Circulation|December 29, 2021
Continued Refinement of the Treatment for Light-Chain Cardiac AmyloidosisJustin L Grodin, Larry D Anderson, Ankit Kansagra
Ejhaem|February 26, 2024
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-upLarry D Anderson, Joan Bladé, Robert A Kyle
Blood|May 1, 2026
How I Treat Plasma Cell LeukemiaSamer Al Hadidi, Frits van Rhee, Larry D Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple MyelomaEthan A Halm, Larry D Anderson, David E Gerber
Frontiers in Oncology|July 3, 2023
Editorial: T-cell directed therapies in multiple myelomaJoshua Richter, Larry D Anderson, Karthik Ramasamy, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Future Oncology (London, England)|December 2, 2021
Idecabtagene vicleucel (ide-cel) CAR T-cell therapy for relapsed and refractory multiple myelomaLarry D Anderson
British Journal of Haematology|January 7, 2022
More key players in the game for myeloma prognosis and therapyLarry D Anderson
Cancers|September 23, 2022
Preface of the Special Issue "COVID-19 Infection and Hematological Malignancies"Mingyi Chen, Larry D Anderson
Clinical Anatomy (New York, N.Y.)|September 1, 2006
Leptomeningeal plaques, a "common" findingRichard M Lovering, Larry D Anderson
Anatomical Science International|January 23, 2009
Architecture and fiber type of the pyramidalis muscleRichard M Lovering, Larry D Anderson
Circulation|December 29, 2021
Continued Refinement of the Treatment for Light-Chain Cardiac AmyloidosisJustin L Grodin, Larry D Anderson, Ankit Kansagra
Ejhaem|February 26, 2024
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-upLarry D Anderson, Joan Bladé, Robert A Kyle
Blood|May 1, 2026
How I Treat Plasma Cell LeukemiaSamer Al Hadidi, Frits van Rhee, Larry D Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple MyelomaEthan A Halm, Larry D Anderson, David E Gerber
Frontiers in Oncology|July 3, 2023
Editorial: T-cell directed therapies in multiple myelomaJoshua Richter, Larry D Anderson, Karthik Ramasamy, et al.
Pageof 12